These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1661195)

  • 1. Fibronectin, cholesterol and triglycerides ascitic fluid concentration in the prediction of malignancy.
    Colloredo Mels G; Bellati G; Auriemma L; Perani C; Leandro G; Vacca N; Pinna N; Alfieri G; Ideo G
    Ital J Gastroenterol; 1991 May; 23(4):179-86. PubMed ID: 1661195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biochemical markers of the tumor origin of ascites].
    Romette J; di Costanzo-Dufetel J
    Pathol Biol (Paris); 1989 Jun; 37(6):720-4. PubMed ID: 2780109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fibronectin in the ascitic fluid: its diagnostic significance].
    Mal F; Nizard G; Labadie H; Trinchet JC; Garnier M; Beaugrand M
    Gastroenterol Clin Biol; 1987 Oct; 11(10):639-42. PubMed ID: 2826281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ascitic fluid cholesterol in malignant and tubercular ascites.
    Sood A; Garg R; Kumar R; Chhina RS; Arora S; Gupta R; Bhatia KL
    J Assoc Physicians India; 1995 Nov; 43(11):745-7. PubMed ID: 8773030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Concentration of lipids in ascitic fluid and the concentration gradient of albumin in blood and ascites: diagnostic significance].
    Barbare JC; Diab G; Delavenne J; Philippe JM; Vorhauer W; Latrive JP; Capron JP
    Ann Gastroenterol Hepatol (Paris); 1989 Nov; 25(6):251-6. PubMed ID: 2619252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of ascitic fibronectin and cholesterol concentration in the differentiation between malignancy-related and non-malignant ascites.
    Archimandritis A; Kapsalas D; Douvara M; Tjivras M; Tsirantonaki M; Fertakis A
    Ann Med Interne (Paris); 1996; 147(3):145-50. PubMed ID: 8796090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of ascitic fluid analysis in patients with malignancy-related ascites.
    Salerno F; Restelli B; Incerti P; Annoni G; Capozza L; Badalamenti S; Lampertico P; Mojana E; Moser P; Tommasini M
    Scand J Gastroenterol; 1990 Mar; 25(3):251-6. PubMed ID: 1690913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of ascitic fluid cholesterol as a marker for malignant ascites.
    Rana SV; Babu SG; Kocchar R
    Med Sci Monit; 2005 Mar; 11(3):CR136-42. PubMed ID: 15735567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of ascitic lipids and sero-ascitic gradient of albumin in the differential diagnosis of ascites].
    Cabral JE; Leitão MC; Guerra C; Tomé L; Pinto ML; Costa D; Monteiro G
    Acta Med Port; 1989; 2(1):17-20. PubMed ID: 2773676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genesis of fibronectin in ascites--detection of cellular and plasma fibronectin in portal and malignant ascites].
    Rieder H; Ramadori G; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1991 Jan; 29(1):16-21. PubMed ID: 2058224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascitic fluid cholesterol in differential diagnosis of ascites.
    Garg R; Sood A; Arora S; Bhatia KL; Chawla AS; Gupta R; Chawla LS
    J Assoc Physicians India; 1993 Oct; 41(10):644-6. PubMed ID: 8294324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of fibronectin in diagnosis of malignant ascites.
    Sood A; Moudgil A; Sood N; Kharay AS; Kaushal S; Narang AP
    J Assoc Physicians India; 1997 Apr; 45(4):283-5. PubMed ID: 12521085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chylous ascites in cirrhotic and non-cirrhotic patients].
    Casafont F; López-Arias MJ; Crespo J; Dueñas C; Sánchez-Antolín G; Rivero M; Pons Romero F
    Gastroenterol Hepatol; 1997; 20(6):291-4. PubMed ID: 9296843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of malignant ascites. Comparison of ascitic fibronectin, cholesterol, and serum-ascites albumin difference.
    Prieto M; Gómez-Lechón MJ; Hoyos M; Castell JV; Carrasco D; Berenguer J
    Dig Dis Sci; 1988 Jul; 33(7):833-8. PubMed ID: 2837370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of fibronectin concentration in benign and malignant ascites.
    Adamsen S; Jönsson P; Brodin B; Lindberg B; Jorpes P
    Eur J Surg; 1991 May; 157(5):325-8. PubMed ID: 1678645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differentiation of malignant and non-malignant origin of ascites by determination of levels of cholesterol and lactate dehydrogenase in ascitic fluid is not absolute].
    Gasko R; Klímová N
    Vnitr Lek; 2000 Jan; 46(1):5-11. PubMed ID: 10953656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosing ascitic etiology on a biochemical basis.
    Bansal S; Kaur K; Bansal AK
    Hepatogastroenterology; 1998; 45(23):1673-7. PubMed ID: 9840127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological parameters in the differential diagnosis of ascites secondary to peritoneal carcinomatosis, hepatic cirrhosis, and congestive heart failure].
    Roldan-Molina F; de Oliveira e Silva A; dos Santos TE; Genzini T; de Miranda MP; de Oliveira RM; Santo GC; D'Albuquerque LA
    Arq Gastroenterol; 1992; 29(2):56-61. PubMed ID: 1284885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
    Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
    Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.